SIGN UP
LOG IN
A
ACIU
AC Immune
2.07
0.05+2.48%After Hours: 2.070 0.00 0.00%16:51 07/03 EDT
OPEN/PREV CLOSE2.000/2.020
TODAY RANGE1.960-2.070
VOL113.29K
MARKET CAP207.85M
52 WEEK RANGE1.430-4.260
AVG VOL (3M)136.22K
% TURNOVER0.11%
TURNOVER--
P/E (TTM)-3.5126
% RANGE5.45%
EPS(TTM)-0.5893
P/E(FORWARD)-2.0491
P/B1.940
BVPS1.067
DIVIDEND--
P/S6.91
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP128.85M
SHARES OUTSTANDING100.41M
NEXT EARNINGS08/04-08/08
FREE FLOAT62.25M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·06/20 10:28
AC Immune SA Announces AGM Results and Strategic Approvals
TipRanks·06/11 20:27
AC Immune SA Announces Leadership Changes in Development Team
TipRanks·05/19 10:57
AC Immune SA Announces Board Changes Ahead of June 2025 AGM
TipRanks·05/06 07:35
AC Immune’s Promising Pipeline and Strong Financial Position Justify Buy Rating
Dow Jones·05/01 12:59
AC Immune Is Maintained at Buy by HC Wainwright & Co.
Dow Jones·05/01 12:59
AC Immune Price Target Cut to $12.00/Share From $16.00 by HC Wainwright & Co.
Benzinga·05/01 12:49
HC Wainwright & Co. Maintains Buy on AC Immune, Lowers Price Target to $12
TipRanks·05/01 10:12
AC Immune price target lowered to $12 from $16 at H.C. Wainwright
Seeking Alpha·04/30 12:09
AC Immune GAAP EPS of -CHF0.19
TipRanks·04/30 11:55
AC Immune Reports Q1 2025 Financial Results
Barchart·04/30 06:14
AC Immune: Q1 Earnings Snapshot
TipRanks·04/04 06:36
AC Immune SA: Promising Phase 2 Results and Positive Outlook Drive Buy Rating
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.